FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | INBX | EDIT | ||
| Company | FS Development Corp II Cl A | Inhibrx Biosciences Inc | Editas Medicine | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 14.08 | 2.39 | ||
| High | 10.16 | 14.27 | 2.54 | ||
| Low | 9.69 | 13.87 | 2.33 | ||
| Last | 9.80 | 14.08 | 2.44 | ||
| Change | -0.20 | +0.10 | +0.07 | ||
| % Change | -2.00% | +0.72% | +2.95% | ||
| Volume | 289,100 | 68,800 | 2,277,400 | ||
| 20-Day Average Volume | 227,795 | 74,855 | 2,226,235 | ||
| Previous Close | 10.00 | 13.98 | 2.37 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 15.31 | 2.89 | ||
| 20-Day Raw Stochastic | 2.99% | 35.47% | 12.73% | ||
| 20-Day Relative Strength | 38.90% | 41.54% | 35.56% | ||
| Weighted Alpha | -13.88 | N/A | -80.73 | ||
| Today's Opinion | 8% Buy | N/A | 100% Sell | ||
| Previous Opinion | 8% Buy | N/A | 100% Sell | ||
| Last Month's Opinion | 72% Buy | N/A | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +1.81% since 11/15/24 | -8.27% since 11/15/24 | ||
| Low | 9.64 on 12/21/21 | 13.27 on 11/19/24 | 2.30 on 11/21/24 | ||
| High | 10.86 on 12/21/21 | 14.63 on 11/21/24 | 2.69 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | -10.89% since 10/22/24 | -25.84% since 10/22/24 | ||
| Low | 9.64 on 12/21/21 | 12.25 on 11/15/24 | 2.30 on 11/21/24 | ||
| High | 15.00 on 12/01/21 | 17.41 on 11/12/24 | 3.40 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | +8.39% since 08/22/24 | -35.62% since 08/22/24 | ||
| Low | 9.64 on 12/21/21 | 12.25 on 11/15/24 | 2.30 on 11/21/24 | ||
| High | 15.05 on 11/19/21 | 17.79 on 09/17/24 | 4.12 on 09/18/24 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | N/A since 05/31/24 | -59.47% since 05/22/24 | ||
| Low | 9.64 on 12/21/21 | 10.80 on 08/12/24 | 2.30 on 11/21/24 | ||
| High | 15.05 on 11/19/21 | 18.95 on 06/05/24 | 6.22 on 06/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,822 | 201,417 | ||
| Shares Outstanding, K | 20,727 | 14,476 | 82,548 | ||
| Annual Sales | 0 | 1,630,000 | 78,120,000 | ||
| Annual Net Income | 0 | -154,960,000 | -153,220,000 | ||
| Last Quarter Sales | 0 | 100,000 | 60,000 | ||
| Last Quarter Net Income | -1,220,000 | 1,858,010,000 | -62,140,000 | ||
| 60-Month Beta | N/A | N/A | 2.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | -2.84 on 11/14/24 | -0.75 on 11/04/24 | ||
| Latest Earnings Date | 10/16/12 | 11/12/24 | 11/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||